Error loading player: No playable sources found
HIV Vaccines: Path to Efficacy
Free
Standard Price
This product is also available as part of the following products:
Keystone Symposia ePanel:
HIV Vaccines: Path to Efficacy
Recorded: March 20 - 24, 2016
Keystone Symposia meeting: HIV Vaccines [X8]
Location: Resort at Squaw Creek, Olympic Valley, CA
___
About Keystone Symposia:
Keystone Symposia is a 501(c)(3) nonprofit organization founded in 1972 that convenes 50-60 open, international scientific research conferences each year across the full range of the life sciences – from cardiovascular disease to immunology to neurobiology. The conferences accelerate life science discovery by bringing together and fostering collaboration among the world’s leading and next generation of research scientists.
Website: www.keystonesymposia.org
Moderator
Gabriella Scarlatti, MD, PhD
Global HIV Vaccine Enterprise
Panelists
General
Related Products
F9, a new class of antibodies that neutralizes autologous tier 2 viruses in NHP immunized with liposome conjugated well-ordered trimers
Recorded during the Keystone Symposia meeting:
Helminths: New Insights from Immunity to Global Health
_AMONG THE DIVERSE PATHOGEN SPECIES KNOWN TO CAUSE MORBIDITY AND MORTALITY IN HUMANS,_ parasitic helminths are by far the most prevalent but least understood…
HIV: Antibody Functions Beyond Neutralization
Antibodies that neutralize HIV can potentially provide sterilizing protection against the virus by blocking infection of cells…
Accelerate to Equal: Engaging Women in Vector Control
ACCELERATE TO EQUAL: ENGAGING WOMEN IN VECTOR CONTROL
